Literature DB >> 19070491

Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review.

M M van der Graaff1, J M B V de Jong, F Baas, M de Visser.   

Abstract

There is an ongoing discussion whether ALS is primarily a disease of upper motor neurons or lower motor neurons. We undertook a review to assess how new insights have contributed to solve this controversy. For this purpose we selected relevant publications from 1995 onwards focussing on (1) primary targets and disease progression in ALS and variants of ALS, (2) brain imaging markers for upper motor neuron lesion, and (3) evidence for ALS being a multisystem disorder. Clinically, upper motor and lower motor neuron symptoms can occur in any order over time. Brain imaging markers show upper motor neuron involvement in early disease. Overlap syndromes of ALS and dementia, and involvement of autonomic and sensory nerves occur frequently. PET/SPECT scans, functional MRI and voxel based morphometry studies clearly show abnormalities in extra-motor areas of the brain. Pathologically, the 43 kDa TAR DNA-binding protein (TDP-43) provides a clue to these overlapping disorders. In conclusion, evidence accumulates that ALS is a multisystem disorder rather than a pure lower and/or upper motor neuron disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070491     DOI: 10.1016/j.nmd.2008.10.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  20 in total

Review 1.  Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Peter W French; Russell Ludowyke; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

2.  Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study.

Authors:  Christina Schuster; Elisabeth Kasper; Judith Machts; Daniel Bittner; Jörn Kaufmann; Reiner Benecke; Stefan Teipel; Stefan Vielhaber; Johannes Prudlo
Journal:  J Neurol       Date:  2013-08-31       Impact factor: 4.849

3.  Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

Authors:  Hongxia Lei; Elisabeth Dirren; Carole Poitry-Yamate; Bernard L Schneider; Rolf Gruetter; Patrick Aebischer
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-05       Impact factor: 6.200

4.  A pilot study of the prevalence of psychiatric disorders in PLS and ALS.

Authors:  Edward D Huey; Jeremy Koppel; Nicole Armstrong; Jordan Grafman; Mary Kay Floeter
Journal:  Amyotroph Lateral Scler       Date:  2010-05-03

5.  Reduced Interhemispheric Functional Connectivity in the Motor Cortex during Rest in Limb-Onset Amyotrophic Lateral Sclerosis.

Authors:  Laura M Jelsone-Swain; Brett W Fling; Rachael D Seidler; Rebecca Hovatter; Kirsten Gruis; Robert C Welsh
Journal:  Front Syst Neurosci       Date:  2010-12-31

6.  Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.

Authors:  John Ravits; Stanley Appel; Robert H Baloh; Richard Barohn; Benjamin Rix Brooks; Lauren Elman; Mary Kay Floeter; Christopher Henderson; Catherine Lomen-Hoerth; Jeffrey D Macklis; Leo McCluskey; Hiroshi Mitsumoto; Serge Przedborski; Jeffrey Rothstein; John Q Trojanowski; Leonard H van den Berg; Steven Ringel
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

7.  G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial.

Authors:  Thomas Duning; Hagen Schiffbauer; Tobias Warnecke; Siawoosh Mohammadi; Agnes Floel; Katja Kolpatzik; Harald Kugel; Armin Schneider; Stefan Knecht; Michael Deppe; Wolf Rüdiger Schäbitz
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

8.  Severe brain atrophy after long-term survival seen in siblings with familial amyotrophic lateral sclerosis and a mutation in the optineurin gene: a case series.

Authors:  Hiroki Ueno; Keitaro Kobatake; Masayasu Matsumoto; Hiroyuki Morino; Hirofumi Maruyama; Hideshi Kawakami
Journal:  J Med Case Rep       Date:  2011-12-12

9.  Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies.

Authors:  Beatrice Nefussy; Vivian E Drory
Journal:  EPMA J       Date:  2010-06-09       Impact factor: 6.543

10.  Amyotrophic lateral sclerosis: a dying motor unit?

Authors:  Maria Piotrkiewicz; Irena Hausmanowa-Petrusewicz
Journal:  Front Aging Neurosci       Date:  2013-03-26       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.